Related Experiment Video
Updated: Jun 11, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Alcohol consumption and rectal tumor mutations and epigenetic changes.
Martha L Slattery1, Roger K Wolff, Jennifer S Herrick
1Department of Medicine, University of Utah, Salt Lake City, Utah 84108, USA. marty.slattery@hsc.utah.edu
Diseases of the Colon and Rectum
|July 15, 2010
Summary
Alcohol consumption, particularly beer, is linked to increased rectal cancer risk and specific tumor mutations like TP53. Different beverage types may influence distinct cancer pathways.
Area of Science:
- Oncology
- Epidemiology
- Molecular Biology
Background:
- Epidemiological studies suggest a link between alcohol consumption and rectal cancer.
- Further research is needed to understand the specific mechanisms and beverage types involved.
Purpose of the Study:
- To investigate the association between alcohol consumption and specific tumor markers in rectal cancer.
- To examine the impact of different types of alcoholic beverages on rectal cancer risk and molecular profiles.
Main Methods:
- Assessed alcohol consumption in rectal cancer cases and population-based controls.
- Analyzed CpG Island Methylator Phenotype (CIMP), TP53, and KRAS2 mutations in relation to alcohol intake.
- Evaluated the effects of recent and long-term alcohol consumption, as well as beverage type.
Main Results:
- A trend of increasing risk for CIMP-positive tumors with long-term alcohol consumption was observed.
- Recent high beer consumption significantly increased the odds of TP53 mutations (OR, 1.97).
- Wine consumption, especially red wine, showed a non-significant trend toward reduced TP53 mutation risk.
Conclusions:
- Alcohol consumption and specific beverage constituents contribute to rectal cancer development.
- Distinct molecular pathways may be involved in alcohol-related rectal carcinogenesis.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:30Spontaneous and Induced Mutations
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...